Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies
Addiction Biology · 2025
DOI: 10.1111/adb.70046 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Addiction Biology, 2025. Verfasst von Leonardo Vázquez-Morales und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Biología, Universidad Veracruzana, Xalapa, Veracruz, Mexico. Hauptthemen laut MEDLINE: Behavior, Addictive, Estrogens, Progesterone, Substance-Related Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología.
Abstract (Originalsprache)
Substance use disorder constitutes a global health challenge. Preclinical investigations into addiction heavily rely on animal models to explore the underlying biological mechanisms of addictive disorders, with a particular emphasis on understanding the etiological factors influencing drug intake. Exploring sex differences across various phases of addiction has revealed a heightened vulnerability in females. This study systematically reviews the impact of ovarian hormones on the consumption of psychoactive substances in rodents, adhering to the PRISMA 2009 protocol. Our findings underscore the significant role of ovarian hormones, particularly oestrogen, in augmenting drug consumption among female rodents. Notably, with heroin, it was observed that progesterone, rather than oestrogen, facilitated increased consumption in female rodents. The susceptibility to addiction influenced by oestrogen is accentuated across distinct phases, and the molecular mechanisms form a complex interplay that significantly influences addictive behaviours. By bringing together these findings, we aim to establish a strong foundation for future studies. This work may guide clinical investigations in developing more effective prevention or treatment strategies that address the unique vulnerabilities of females to substance use disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Biología, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
- Laboratorio de Neurobiología de la Conducta y Procesos Neuroquímicos, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
- Facultad de Química Farmacéutica Biológica, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
- Laboratorio de Biomedicina Integral y Salud, Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
- Laboratorio de Medicina Traslacional, Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico.
ORCID-Profile: Leonardo Vázquez-Morales, Tania Molina-Jiménez, Rossana C Zepeda, Óscar López-Franco, Mónica Flores-Muñoz, Claudia Juárez-Portilla
Förderung
- Consejo Nacional de Ciencia y Tecnología
Zitieren
APA
Vázquez-Morales, L., Aguirre, G., Molina-Jiménez, T., Zepeda, R. C., López-Franco, Ó., Flores-Muñoz, M., & Juárez-Portilla, C. (2025). Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies. Addiction Biology. https://doi.org/10.1111/adb.70046
Vancouver
Vázquez-Morales L, Aguirre G, Molina-Jiménez T, Zepeda RC, López-Franco Ó, Flores-Muñoz M, et al. Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies. Addiction Biology. 2025. doi:10.1111/adb.70046
BibTeX
@article{VzquezMorales2025,
author = {Vázquez-Morales, Leonardo and Aguirre, Gisela and Molina-Jiménez, Tania and Zepeda, Rossana C and López-Franco, Óscar and Flores-Muñoz, Mónica and Juárez-Portilla, Claudia},
title = {Ovarian Hormones and Addictive Behaviour Vulnerability: Insights From Preclinical Studies},
journal = {Addiction Biology},
year = {2025},
doi = {10.1111/adb.70046}
}
EUVIMED